ROYSTON IVOR
SEC insider (Form 3/4/5 filer). CIK 0001026765. Director at Viracta Therapeutics, Inc. (VIRX). 2 reported Form 4/5 transactions since Sep 2024; latest on Nov 25, 2024. Located in CARDIFF, CA.
Companies ROYSTON IVOR has filed insider reports for
- Viracta Therapeutics, Inc. (VIRX): Director
ROYSTON IVOR
CIK: 0001026765
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VIRX
Viracta Therapeutics, Inc.
Director